Active substance
Captopril
- SFDA 16
- US FDA 27
- Health Canada 9
- US price lines 4
- NHS prices 5
- Safety 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| ACETAB 25 MG TABLETS | 25 mg | Tablet · Oral use | 30 Blister | SAR 20.25 | Generic · Prescription | KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES | Valid |
| ACETAB 50 MG TABLETS | 50 mg | Tablet · Oral use | 30 Blister | SAR 34.20 | Generic · Prescription | KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES | Valid |
| Acetab | 1 mg/ml | Oral solution · Oral use | 1 Bottle | SAR 133.40 | Generic · Prescription | KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES | Valid |
| CAPOCARD 25MG TAB | 25 mg | Tablet · Oral use | 20 Blister | SAR 15.15 | Generic · Prescription | DAR ALDAWA | Valid |
| CAPOCARD 50MG TAB | 50 mg | Tablet · Oral use | 20 Blister | SAR 25.40 | Generic · Prescription | DAR ALDAWA | Valid |
| CAPRIL 25MG TAB | 25 mg | Tablet · Oral use | 20 Blister | SAR 18.65 | Generic · Prescription | SPIMACO ADDWAEIH | Valid |
| CAPRIL 50MG TAB | 50 mg | Tablet · Oral use | 20 Blister | SAR 31.55 | Generic · Prescription | SPIMACO ADDWAEIH | Valid |
| NOYADA 25MG/5ML ORAL SOLUTION | 5 mg | Oral solution · Oral use | 1 Bottle | SAR 165.00 | NCE · Prescription | MACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALS | Valid |
| NOYADA 5MG/5ML ORAL SOLUTION | 1 mg | Oral solution · Oral use | 1 Bottle | SAR 140.40 | NCE · Prescription | MACARTHYS LABORATORIES Ltd T/A MARTINDALE PHARMACEUTICALS | Valid |
| CAPOTEN 25MG TAB | 25 mg | Tablet · Oral use | 20 Blister | SAR 18.65 | NCE · Prescription | SPIMACO ADDWAEIH | Withdrawn by MAH · Not Marketed |
| CAPOTEN 50MG TAB | 50 mg | Tablet · Oral use | 20 Blister | SAR 31.55 | NCE · Prescription | SPIMACO ADDWAEIH | Withdrawn by MAH · Not Marketed |
| CAPTOPHAR 25MG TABLETS | 25 mg | Tablet · Oral use | 30 Blister | SAR 17.80 | Generic · Prescription | Gulf Pharmaceutical Industries (Julphar) | Withdrawn by MAH · Not Marketed |
| CAPTOPHAR 50MG TABLETS | 50 mg | Tablet · Oral use | 28 Blister | SAR 28.10 | Generic · Prescription | Gulf Pharmaceutical Industries (Julphar) | Withdrawn by MAH · Not Marketed |
| NOVO-CAPTORIL 12.5MG TAB | 12.5 mg | Tablet · Oral use | 20 Blister | SAR 11.55 | Generic · Prescription | NOVOPHARM | Withdrawn by MAH · Not Marketed |
| NOVO-CAPTORIL 25MG TAB | 25 mg | Tablet · Oral use | 20 Blister | SAR 18.25 | Generic · Prescription | NOVOPHARM | Withdrawn by MAH · Not Marketed |
| NOVO-CAPTORIL 50MG TAB | 50 mg | Tablet · Oral use | 20 Blister | SAR 29.10 | Generic · Prescription | NOVOPHARM | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
CARDIOMYOPATHY; CHRONIC KIDNEY DISEASE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; HYPERTENSION; NON-ST WAVE ELEVATED MYOCARDIAL INFARCTION (NSTEMI); SICKLE CELL DISEASE - ALBUMINURIA MANAGEMENT; ST-WAVE ELEVATED MYOCARDIAL INFARCTION (STEMI)
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| CAPTOPRIL | 12.5MG; 25MG; 50MG; 100MG | tablet · oral | PRINSTON INC | Prescription | 13 Feb 1996 |
| CAPTOPRIL | 12.5MG; 25MG; 50MG; 100MG | tablet · oral | HIKMA INTL PHARMS | Prescription | 13 Feb 1996 |
| CAPTOPRIL | 12.5MG; 25MG; 50MG; 100MG | tablet · oral | WOCKHARDT BIO AG | Prescription | 28 Mar 1997 |
| CAPTOPRIL | 50MG; 25MG; 100MG; 12.5MG | tablet · oral | ANDAS 5 HOLDING | Prescription | 30 May 1997 |
| CAPTOPRIL | 12.5MG; 25MG; 50MG; 100MG | tablet · oral | COREPHARMA | Prescription | 28 Oct 1998 |
| CAPTOPRIL | 12.5MG; 25MG; 50MG; 100MG | tablet · oral | AJANTA PHARMA LTD | Prescription | 13 Dec 2019 |
| CAPTOPRIL | 12.5MG; 25MG; 50MG; 100MG | tablet · oral | AIPING PHARM INC | Prescription | 27 Jan 2023 |
| CAPOTEN | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 37.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | AARXION ANDA HLDING | Discontinued | 6 Apr 1981 |
| CAPTOPRIL | 12.5MG; 25MG; 50MG; 100MG | tablet · oral | APOTHECON | Discontinued | 31 Mar 1995 |
| CAPTOPRIL | 12.5MG; 25MG; 50MG; 100MG | tablet · oral | CHARTWELL RX | Discontinued | 9 Nov 1995 |
| CAPTOPRIL | 12.5MG; 25MG; 50MG; 100MG | tablet · oral | TEVA | Discontinued | 13 Feb 1996 |
| CAPTOPRIL | 12.5MG; 25MG; 50MG; 100MG | tablet · oral | TP ANDA HOLDINGS | Discontinued | 13 Feb 1996 |
| CAPTOPRIL | 12.5MG; 25MG; 50MG; 100MG | tablet · oral | DAVA PHARMS INC | Discontinued | 13 Feb 1996 |
| CAPTOPRIL | 12.5MG; 25MG; 50MG; 100MG | tablet · oral | COSETTE PHARMS NC | Discontinued | 13 Feb 1996 |
| CAPTOPRIL | 12.5MG; 25MG; 50MG; 100MG | tablet · oral | AUROBINDO PHARMA USA | Discontinued | 13 Feb 1996 |
| CAPTOPRIL | 12.5MG; 25MG; 50MG; 100MG | tablet · oral | WATSON LABS | Discontinued | 13 Feb 1996 |
| CAPTOPRIL | 12.5MG; 25MG; 50MG; 100MG | tablet · oral | COSETTE PHARMS NC | Discontinued | 13 Feb 1996 |
| CAPTOPRIL | 12.5MG; 25MG; 50MG; 100MG | tablet · oral | SANDOZ | Discontinued | 13 Feb 1996 |
| CAPTOPRIL | 12.5MG; 25MG; 50MG; 100MG | tablet · oral | COSETTE PHARMS NC | Discontinued | 13 Feb 1996 |
| CAPTOPRIL | 12.5MG; 25MG; 50MG; 100MG | tablet · oral | STRIDES PHARMA INTL | Discontinued | 13 Feb 1996 |
| CAPTOPRIL | 12.5MG; 25MG; 50MG; 100MG | tablet · oral | CHARTWELL RX | Discontinued | 13 Feb 1996 |
| CAPTOPRIL | 12.5MG; 25MG; 50MG; 100MG | tablet · oral | WATSON LABS | Discontinued | 23 Apr 1996 |
| CAPTOPRIL | 12.5MG; 25MG; 50MG; 100MG | tablet · oral | WATSON LABS | Discontinued | 23 May 1996 |
| CAPTOPRIL | 50MG; 25MG; 100MG; 12.5MG | tablet · oral | G AND W LABS INC | Discontinued | 30 Aug 1996 |
| CAPTOPRIL | 50MG; 25MG; 100MG; 12.5MG | tablet · oral | EGIS PHARMS | Discontinued | 29 May 1997 |
2 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| APO-CAPTO TAB 100MG | 00893625 | 100 MG | TABLET · ORAL | APOTEX INC |
| APO-CAPTO TAB 12.5MG | 00893595 | 12.5 MG | TABLET · ORAL | APOTEX INC |
| APO-CAPTO TAB 50MG | 00893617 | 50 MG | TABLET · ORAL | APOTEX INC |
| NOYADA | 02543907 | 5 MG / 5 ML | SOLUTION · ORAL | ETHYPHARM INC |
| NOYADA | 02543915 | 25 MG / 5 ML | SOLUTION · ORAL | ETHYPHARM INC |
| TEVA-CAPTOPRIL | 01942964 | 12.5 MG | TABLET · ORAL | TEVA CANADA LIMITED |
| TEVA-CAPTOPRIL | 01942972 | 25 MG | TABLET · ORAL | TEVA CANADA LIMITED |
| TEVA-CAPTOPRIL | 01942980 | 50 MG | TABLET · ORAL | TEVA CANADA LIMITED |
| TEVA-CAPTOPRIL | 01942999 | 100 MG | TABLET · ORAL | TEVA CANADA LIMITED |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | CAPTOPRIL 100 MG TABLET | $0.32292 | per EA | 2 Sep 2026 |
| US NADAC | CAPTOPRIL 12.5 MG TABLET | $0.22839 | per EA | 23 Sep 2026 |
| US NADAC | CAPTOPRIL 25 MG TABLET | $0.17282 | per EA | 23 Sep 2026 |
| US NADAC | CAPTOPRIL 50 MG TABLET | $0.36903 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Captopril 12.5mg tablets | £28.17 | 56 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Captopril 25mg tablets | £57.63 | 56 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Captopril 25mg/5ml oral solution sugar free | £101.00 | 100 ml | 1 Oct 2026 |
| NHS Drug Tariff | Captopril 50mg tablets | £55.13 | 56 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Captopril 5mg/5ml oral solution sugar free | £93.30 | 100 ml | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 1 Aug 2017 CAPOTEN — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions
Combinations containing Captopril
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.